- 1次围观
产品图片
货号/SKU
NR-46240
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-46240??Staphylococcus aureus, NY-245(Bacteria)|Staphylococcus aureus|NY-245| -60°C or colder|CDCAcknowledgment for publications should read “The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain NY-245, NR-46240.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain NY-245 (also referred to as NRS711) was isolated in 2005 from bone of a 65-year-old male inpatient in New York, USA.
S. aureus, strain NY-245 is a methicillin-resistant S. aureus (MRSA) strain. Strain NY-245 was deposited as positive for mec (subtype II); negative for the toxic shock syndrome toxin (TSST) and the Panton–Valentine leukocidin (PVL) cytotoxin. It was deposited as susceptible to daptomycin, doxycycline, gentamicin, linezolid, rifampin, tetracycline, trimethoprim/sulfamethoxazole and vancomycin, intermediately susceptible to chloramphenicol and resistant to clindamycin, erythromycin, levofloxacin, oxacillin and penicillin. S. aureus, strain NY-245 is a Pulsed-Field Gel Electrophoresis (PFGE) type USA100 isolate. USA100 isolates have the same MLST profile (ST 5) and SCCmec (subtype II) and are usually resistant to ?-lactams, erythromycin and spectinomycin as well as being multiresistant to other commonly used therapeutic agents. USA100 is the most prevalent U.S. health care-associated pulsed-field type and is endemic in many U.S. hospitals.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Staphylococcus aureus (S. aureus), strain NY-245 (also referred to as NRS711) was isolated in 2005 from bone of a 65-year-old male inpatient in New York, USA.
S. aureus, strain NY-245 is a methicillin-resistant S. aureus (MRSA) strain. Strain NY-245 was deposited as positive for mec (subtype II); negative for the toxic shock syndrome toxin (TSST) and the Panton–Valentine leukocidin (PVL) cytotoxin. It was deposited as susceptible to daptomycin, doxycycline, gentamicin, linezolid, rifampin, tetracycline, trimethoprim/sulfamethoxazole and vancomycin, intermediately susceptible to chloramphenicol and resistant to clindamycin, erythromycin, levofloxacin, oxacillin and penicillin. S. aureus, strain NY-245 is a Pulsed-Field Gel Electrophoresis (PFGE) type USA100 isolate. USA100 isolates have the same MLST profile (ST 5) and SCCmec (subtype II) and are usually resistant to ?-lactams, erythromycin and spectinomycin as well as being multiresistant to other commonly used therapeutic agents. USA100 is the most prevalent U.S. health care-associated pulsed-field type and is endemic in many U.S. hospitals.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
金黄色葡萄球菌(金黄色葡萄球菌),菌株NY-245(也称为NRS711)于2005年从美国纽约的65岁男性住院病人的骨中分离出来.
s.金黄色葡萄球菌,菌株NY-245是耐甲氧化素的.金黄色葡萄球菌(MRSA)菌株.将菌株NY-245沉积为阳性的 mec (亚型II);毒性休克综合征毒素(TSST)和Panton-valentine白霉素(PVL)细胞毒素的阴性.它被沉积易于达达霉素,强霉素,庆大霉素,线唑胺,利福平,四环素,三甲基氯唑和磺霉素,中等易于氯霉素,抗克林霉素,红霉素,左氧氟普林,牛奶菌素和青霉素. s.金黄色葡萄球菌,菌株NY-245是脉冲场凝胶电泳(PFGE)型USA100分离物. USA100.
分离株具有相同的MLST型(ST 5)和SCC MEC (亚型II),并且通常抵抗β-内酰胺,红霉素和北霉素以及多粘剂与其他常用的治疗剂. USA100是最普遍的美国医疗保健相关的脉冲场类型,在许多美国医院的地方是流行的.
每个小瓶在补充有10%甘油的胰蛋白酶肉汤中含有约0.5ml细菌培养物.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2021-12-21
2024-09-22
2022-04-01
2024-10-20
2021-12-21
2022-03-31
2024-05-19
2022-04-01
2021-12-13
2024-06-25
2022-04-01